e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Invesco Pharmaceuticals ETF
(NY:
PJP
)
107.24
+1.44 (+1.36%)
Streaming Delayed Price
Updated: 2:19 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,798
Open
105.67
Bid (Size)
106.94 (100)
Ask (Size)
107.04 (100)
Prev. Close
105.80
Today's Range
105.67 - 107.26
52wk Range
72.25 - 107.05
Shares Outstanding
28,900
Dividend Yield
0.88%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report
↗
December 01, 2025
The report states that the agreement between the U.S. and the U.K. is expected to be announced in the coming days.
Via
Stocktwits
Topics
World Trade
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
↗
November 12, 2025
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
Via
Benzinga
Performance
YTD
+29.2%
+29.2%
1 Month
+3.0%
+3.0%
3 Month
+15.6%
+15.6%
6 Month
+34.2%
+34.2%
1 Year
+30.1%
+30.1%
More News
Read More
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
↗
September 29, 2025
Via
Benzinga
Topics
Government
World Trade
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided
↗
July 21, 2025
Via
Stocktwits
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
↗
September 08, 2025
Via
Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
↗
August 01, 2025
Via
Benzinga
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
↗
July 16, 2025
Via
Benzinga
Topics
Government
World Trade
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report
↗
July 11, 2025
Via
Stocktwits
Topics
Government
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
↗
July 11, 2025
Via
Benzinga
Topics
Government
World Trade
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
↗
June 20, 2025
Via
Benzinga
FDA Aims To Reduce Drug Application Review Time With New Voucher Program
↗
June 17, 2025
Via
Stocktwits
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
↗
May 19, 2025
Via
Benzinga
Topics
Government
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
↗
May 11, 2025
Via
Benzinga
Topics
Government
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
↗
April 28, 2025
Via
Stocktwits
Topics
Government
Intellectual Property
Lawsuit
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
↗
April 23, 2025
Via
Benzinga
Topics
Government
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
↗
April 11, 2025
Via
Benzinga
Topics
Government
World Trade
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
↗
November 13, 2024
Via
Benzinga
Topics
Government
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
↗
August 19, 2024
Via
Benzinga
Topics
ETFs
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
↗
July 18, 2024
Via
Benzinga
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
↗
June 27, 2024
Via
Benzinga
Topics
Bankruptcy
Lawsuit
A Look At Pharma ETFs Post Q1 Earnings
↗
May 07, 2024
Via
Talk Markets
Topics
ETFs
A Look At Pharma ETFs After Q4 Earnings
↗
February 12, 2024
Via
Talk Markets
Topics
ETFs
Government-granted Patent Monopolies Are Not The Free Market
↗
December 29, 2023
Via
Talk Markets
Topics
Intellectual Property
Time For Gilead Sciences-Heavy ETFs?
↗
September 12, 2023
Via
Talk Markets
Pharma ETFs in Focus Post Q2 Earnings
↗
August 11, 2023
Via
Talk Markets
Topics
ETFs
Frequently Asked Questions
Is Invesco Pharmaceuticals ETF publicly traded?
Yes, Invesco Pharmaceuticals ETF is publicly traded.
What exchange does Invesco Pharmaceuticals ETF trade on?
Invesco Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Pharmaceuticals ETF?
The ticker symbol for Invesco Pharmaceuticals ETF is PJP on the New York Stock Exchange
What is the current price of Invesco Pharmaceuticals ETF?
The current price of Invesco Pharmaceuticals ETF is 107.24
When was Invesco Pharmaceuticals ETF last traded?
The last trade of Invesco Pharmaceuticals ETF was at 12/19/25 02:19 PM ET
What is the market capitalization of Invesco Pharmaceuticals ETF?
The market capitalization of Invesco Pharmaceuticals ETF is 3.10M
How many shares of Invesco Pharmaceuticals ETF are outstanding?
Invesco Pharmaceuticals ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.